These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

44 related articles for article (PubMed ID: 4568037)

  • 1. [Comparative biological actions of different depot glucagons and standard glucagon].
    Assan R; Delaunay J
    Pathol Biol (Paris); 1972 Dec; 20(23):979-84. PubMed ID: 4568037
    [No Abstract]   [Full Text] [Related]  

  • 2. [Zinc-protamine-glucagon in the therapy of heart failure].
    Kaindl F; Kühn P
    Z Gesamte Inn Med; 1972 Dec; 27(24):1097-8. PubMed ID: 4654564
    [No Abstract]   [Full Text] [Related]  

  • 3. [Therapy of heart failure using zinc-protamine-glucagon].
    Kühn P
    Z Kardiol; 1973 Aug; 62(8):728-40. PubMed ID: 4779156
    [No Abstract]   [Full Text] [Related]  

  • 4. [Zinc protamine glucagon in refractory heart failure with arrhythmia].
    Gamba S; Turbiglio PC; Bollati C; Bruni B
    Minerva Med; 1977 Nov; 68(53):3613-26. PubMed ID: 339129
    [No Abstract]   [Full Text] [Related]  

  • 5. [Cardiological use of glucagon-zinc-protamine in diabetes].
    Bruni B
    Minerva Med; 1972 Nov; 63(83):4513-9. PubMed ID: 4404792
    [No Abstract]   [Full Text] [Related]  

  • 6. The effect of a long-acting glucagon preparation on endocrine and metabolic responses in acute myocardial infarction.
    Arstila M; Iisalo E; Kallio V; Nousiainen R; Viljanen M
    Acta Med Scand; 1974 Nov; 196(5):423-30. PubMed ID: 4440520
    [No Abstract]   [Full Text] [Related]  

  • 7. [Comparative effects of glucagon injection in normal-weight and obese nondiabetic subjects. Preliminary report].
    Scornavachi JC; Vague P; Rouvier-Leroy C
    Diabete; 1968; 16(2):126-31. PubMed ID: 4923394
    [No Abstract]   [Full Text] [Related]  

  • 8. Subcutaneous glucagon-like peptide-1 improves postprandial glycaemic control over a 3-week period in patients with early type 2 diabetes.
    Todd JF; Edwards CM; Ghatei MA; Mather HM; Bloom SR
    Clin Sci (Lond); 1998 Sep; 95(3):325-9. PubMed ID: 9730852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased responses of glucagon and glucose production to hypoglycemia with intraperitoneal versus subcutaneous insulin treatment.
    Wan CK; Giacca A; Matsuhisa M; El-Bahrani B; Lam L; Rodgers C; Shi ZQ
    Metabolism; 2000 Aug; 49(8):984-9. PubMed ID: 10954014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucagon-like peptide 1 (GLP-1) in the treatment of diabetes.
    Nauck MA
    Horm Metab Res; 2004; 36(11-12):852-8. PubMed ID: 15655719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evaluation of the metabolic action of glucagon in subjects undergoing anti-insulin therapy].
    Marugo M; Mortara R; Baiardi M; Giusti M; Motta A; Grimaldi GP
    Clin Ter; 1981 Mar; 96(6):579-92. PubMed ID: 7026132
    [No Abstract]   [Full Text] [Related]  

  • 12. The effect of zinc-protamine-glucagon in acute pancreatitis.
    Kalima TV; Lempinen M
    Ann Chir Gynaecol; 1980; 69(6):293-5. PubMed ID: 6163389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum immunoreactive insulin (IRI) release following subcutaneous administration of glucagon in 17 normal children.
    Florea I; Popa M; Simionescu L
    Folia Endocrinol; 1974 Jun; 27(3):259-64. PubMed ID: 4597340
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of delayed-action glucagon on stomach secretion in man].
    Ottenjann R; Rösch W; Deyhle P
    Med Klin; 1972 Apr; 67(14):479-81. PubMed ID: 5042081
    [No Abstract]   [Full Text] [Related]  

  • 15. Defective amplification of the late phase insulin response to glucose by GIP in obese Type II diabetic patients.
    Vilsbøll T; Krarup T; Madsbad S; Holst JJ
    Diabetologia; 2002 Aug; 45(8):1111-9. PubMed ID: 12189441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hemodynamic changes following acute myocardial ischemia and zinc-protamine-glucagon application in dogs (author's transl)].
    Losert U; Ramadan I; Wolner E
    Arzneimittelforschung; 1980; 30(1):5-9. PubMed ID: 7370075
    [No Abstract]   [Full Text] [Related]  

  • 17. Inhibition of glucagon secretion.
    Young A
    Adv Pharmacol; 2005; 52():151-71. PubMed ID: 16492545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Nesidioblastosis. Long-term treatment of hypoglycemia with zinc-protamine glucagon].
    Storm K; Christensen PE
    Ugeskr Laeger; 1982 Aug; 144(31):2296-7. PubMed ID: 7147445
    [No Abstract]   [Full Text] [Related]  

  • 19. Glycaemic effects of incretins in Type 1 diabetes mellitus: a concise review, with emphasis on studies in humans.
    Dupre J
    Regul Pept; 2005 Jun; 128(2):149-57. PubMed ID: 15780434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Metabolic effect of glucagon in chronic cardiac insufficiency].
    Franke F; Berchthold P; Simon H
    Med Welt; 1972 Oct; 23(41):1421-3. PubMed ID: 5087189
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.